Lack of binding of acetaminophen to 5-HT receptor or uptake sites (or eleven other binding/uptake assays)

Life Sciences

Volumn 59, Issue 2, 1996, Pages 37-40

  Raffa, Robert B ^a   Codd, Ellen E ^a  

^a R W JOHNSON PHARMACEUTICAL RES I   (United States)

Author keywords

5 HT receptors; Acetaminophen; Analgesia; Paracetamol; Receptor assays; Uptake sites

Indexed keywords

PARACETAMOL; RECEPTOR SUBTYPE; SEROTONIN RECEPTOR;

ANALGESIA; ARTICLE; BINDING AFFINITY; DRUG RECEPTOR BINDING; LIGAND BINDING; PAIN;

ACETAMINOPHEN; ANIMALS; BINDING, COMPETITIVE; CATTLE; CEREBRAL CORTEX; GUINEA PIGS; HEART; RATS; RECEPTORS, SEROTONIN; SWINE;

EID: 0030011682     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/0024-3205(96)00273-1     Document Type: Article

References (28)

1. B. BANNWARTH, F. DEMOTES-MAINARD, T. SCHAEVERBEKE, L. LABAT and J. DEHAIS, Fundam. Clin. Pharmacol. 9 1-7 (1995).
2. B. AMEER and D.J. GREENBLATT, Ann. Intern. Med. 87 202-209 (1977).
3. T. PELISSIER, A. ALLOUI, C. PAEILE and A. ESCHALIER, NeuroReport 6 1546-1548 (1995).
4. P. GREENGRASS and R. BREMNER, Eur. J. Pharmacol. 55 323-326 (1979).
5. S. UHLEN and J.E. WIKBERG, Pharmacol. Toxicol. 69 341-350 (1991).
6. T. ABRAHAMSSON, B. EK and V. NERME, Biochem. Pharmacol. 37 203-208 (1988).
7. M. TRAMPUS, E. ONGINI, K. VARANI and A. BOREA, Eur. J. Pharmacol. 194 17-23 (1991).
8. M. TERAI, K. HIDAKA and Y. NAKAMURA, Eur. J. Pharmacol. 173 177-182 (1989).
9. M. ENTZEROTH and N. MAYER, Biochem. Pharmacol. 40 1674-1676 (1990).
10. R. PATACCHINI, M. ASTOLFI, M.C.S. BROWN and C.A. MAGGI, Neuropeptides 20 109-114 (1991).
11. M. GOLDSTEIN, N. KUSFINO, C. ADLER and E. MELLER, Progr. Brain Res. 68 331-335 (1986).
12. S.R. CHILDERS, I. CREESE, A.M. SNOWMAN and S.H. SNYDER, Eur. J. Pharmacol. 55 11-18 (1979).
13. M.D. HALL, S. EL MESTIKAWY, M.B. EMERIT, L. PICHAT, M. HAMON and H. GOZLAN, J. Neurochem. 44 1685-1696 (1985).
14. D. HOYER, G. ENGEL and H.O. KALKMAN, Eur. J. Pharmacol. 118 1-12 (1985).
15. R.E. HEURING and S.J. PEROUTKA, J. Neurosci. 7 894-903 (1987).
16. J.E. LEYSEN, C.J.E. NIEMEGEERS, J.M. VAN NUETEN and P.M. LADURON, Mol. Pharmacol. 21 301-314 (1982).
17. A. PAZOS, D. HOYER and J.M. PALACIOS, Eur. J. Pharmacol. 106 539-546 (1984).
18. D. HOYER and H.C. NEIJT, Mol. Pharmacol. 33 303-309 (1988).
19. C.J. GROSSMAN, G.J. KILPATRICK and K.T. BUNCE, Br. J. Pharmacol. 109 618-624 (1993).
20. F.J. MONSMA, Y. SHEN, R.P. WARD, M.W. HAMBLIN and D.R. SIBLEY, Mol. Pharmacol. 43 320-327 (1993).
21. Y. SHEN, F.J. MONSMA, M.A. METCALF, P.A. JOSE, M.W. HAMBLIN and D.R. SIBLEY, J. Biol. Chem. 268 18200-18204 (1993).
22. E.W. KARBON, K. NAPER and M.J. PONTECORVO, Eur. J. Pharmacol. 193 21-27 (1991).
23. J.O. MARCUSSON, M. BERGSTROM, K. ERIKSSON and S.V. ROSS, J. Neurochem. 50 1783-1790 (1988).
24. S.M. TEJANI-BUTT, J. Pharmacol. Exp. Ther. 260 427-436 (1992).
25. A. TJØLSEN, A. LUND and K. HOLE, Eur. J. Pharmacol. 193 193-201 (1991).
26. T. PÉLISSIER, A. ALLOUI, F. CAUSSADE, A. CLOAREC, J. LAVARENNE and A. ESCHALIER, Fundam. Clin. Pharmacol. 8 263 (1994).
27. E.C.M. de LANGE, M. DANHOF, A.G. de BOER and D.D. BREIMER, Br. Res. 666 1-8 (1994).
28. M.D. RAWLINS, D.B. HENDERSON nad A.R. HIJAB, Eur. J. Clin. Pharmacol. 11 283-286 (1977).